Table of Content

1. Introduction


2. Research & Methodology

3. Executive Summary


4. Market Dynamic

4.1 Growth Driver
4.2 Challenges


5. Global Hepatitis C Drugs Market


6. Market Share Analysis - Global Hepatitis C Drugs

6.1 Regions
6.2 Drugs
6.3 Distribution Channels
6.4 Company


7. Regions - Global Hepatitis C Drugs Market

7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 Latin America
7.5 Middle East & Africa


8. Drugs - Global Hepatitis C Drugs Market

8.1 Mavyret
8.2 Viekira Pak
8.3 Harvoni
8.4 Epclusa
8.5 Sovaldi
8.6 Vosevi
8.7 Zepatier
8.8 Others


9. Distribution Channels - Global Hepatitis C Drugs Market

9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacy


10. Merger and Acquisitions


11. Company Analysis - Global Hepatitis C Drugs Market

11.1 Abbvie

11.1.1 Recent Development or Strategy
11.1.2 Revenue

11.2 Gilead Sciences, Inc.

11.2.1 Recent Development or Strategy
11.2.2 Revenue

11.3 Merck & Co. Inc.

11.3.1 Recent Development or Strategy
11.3.2 Revenue

11.4 Bristol-Myers Squibb

11.4.1 Recent Development or Strategy
11.4.2 Revenue

11.5 Others



List of Figures


Figure-01: Global Hepatitis C Drug Market, (Billion US$), 2016 - 2019
Figure-02: Global Hepatitis C Drug Market Forecast, (Billion US$), 2020 - 2025
Figure-03: Global - Hepatitis C Drugs Market Share Analysis by Regions (Percent), 2016 – 2019
Figure-04: Global - Forecast for Hepatitis C Drugs Market Share Analysis by Regions (Percent), 2020 – 2025
Figure-05: Global - Hepatitis C Drugs Market Share Analysis by Distribution Channels(Percent), 2016 – 2019
Figure-06: Global - Forecast for Hepatitis C Drugs Market Share Analysis by Distribution Channels (Percent), 2020 – 2025
Figure-07: North America – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-08: North America – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-09: Europe – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-10: Europe – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-11: Asia Pacific– Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-12: Asia Pacific– Forecast Hepatitis C Drug Market, (Million US$), 2020- 2025
Figure-13: Latin America – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-14: Latin America – Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-15: Middle East & Africa – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-16: Middle East & Africa – Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-17: Mavyret – Hepatitis C Drug Market, (Million US$), 2017 - 2019
Figure-18: Mavyret – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-19: Viekira Pak – Hepatitis C Drug Market, (Million US$), 2016 2019
Figure-20: Viekira Pak – Forecast for Hepatitis C Drug Market, (Million US$), 2020 -2025
Figure-21: Harvoni–Hepatitis C Drug Market, (Million US$), 2016- 2019
Figure-22: Harvoni – Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-23: Epclusa – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-24: Epclusa– Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-25: Sovaldi– Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-26: Sovaldi– Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-27: Vosevi– Hepatitis C Drug Market, (Million US$), 2017- 2019
Figure-28: Vosevi– Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-29: Zepatier–Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-30: Zepatier – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-31: By Distribution Channels - Hospital Pharmacies Market (Million US$), 2016 – 2019
Figure-32: By Distribution Channels - Forecast For Hospital Pharmacies Market (Million US$), 2020 – 2025
Figure-33: By Distribution Channels - Retail Pharmacies Market (Million US$), 2016 – 2019
Figure-34: By Distribution Channels - Forecast For Retail Pharmacies Market (Million US$), 2020 – 2025
Figure-35: By Distribution Channels - Online Pharmacy Market (Million US$), 2016 – 2019
Figure-36: By Distribution Channels - Forecast For Retail Pharmacies Market (Million US$), 2020 – 2025
Figure-37: Global - Abbvie Company Revenue Market (Million US$), 2016 – 2019
Figure-38: Global - Abbvie Company Forecasted Revenue (Million US$), 2020 – 2025
Figure-39: Global - Gilead Sciences, Inc Revenue (Million US$), 2016 – 2019
Figure-40: Global - Gilead Sciences, Inc Forecasted Revenue (Million US$), 2020 – 2025
Figure-41: Global - Merck & Co. Inc. Company Revenue (Million US$), 2016 – 2019
Figure-42: Global - Merck & Co. Inc. Company Forecasted Revenue (Million US$), 2020 – 2025
Figure-43: Global - Bristol-Myers Squibb Company Revenue (Million US$), 2016 – 2018
Figure-44: Other Company - Revenue (Million US$), 2016 – 2019
Figure-45: Other Company - Forecasted Revenue (Million US$), 2020 – 2025


List of Tables


Table-01: Global - Hepatitis C Drugs Market Share Analysis by Drugs (Percent), 2016 – 2019
Table-02: Global - Forecast For Hepatitis C Drugs Market Share Analysis by Drugs (Percent), 2020 – 2025
Table-03: Global - Hepatitis C Drugs Market Share Analysis by Company (Percent), 2016 – 2019
Table-04: Global - Forecast for Hepatitis C Drugs Market Share Analysis by Company (Percent), 2020 – 2025